Bartolome F

References (3)

Title : Multitarget drugs as potential therapeutic agents for alzheimer's disease. A new family of 5-substituted indazole derivatives as cholinergic and BACE1 inhibitors - Gonzalez-Naranjo_2022_J.Enzyme.Inhib.Med.Chem_37_2348
Author(s) : Gonzalez-Naranjo P , Perez C , Gonzalez-Sanchez M , Gironda-Martinez A , Ulzurrun E , Bartolome F , Rubio-Fernandez M , Martin-Requero A , Campillo NE , Paez JA
Ref : J Enzyme Inhib Med Chem , 37 :2348 , 2022
Abstract :
PubMedSearch : Gonzalez-Naranjo_2022_J.Enzyme.Inhib.Med.Chem_37_2348
PubMedID: 36050834

Title : Targeting Cannabinoid Receptor Activation and BACE-1 Activity Counteracts TgAPP Mice Memory Impairment and Alzheimer's Disease Lymphoblast Alterations - Nunez-Borque_2020_Mol.Neurobiol__
Author(s) : Nunez-Borque E , Gonzalez-Naranjo P , Bartolome F , Alquezar C , Reinares-Sebastian A , Perez C , Ceballos ML , Paez JA , Campillo NE , Martin-Requero A
Ref : Molecular Neurobiology , : , 2020
Abstract :
PubMedSearch : Nunez-Borque_2020_Mol.Neurobiol__
PubMedID: 31898159

Title : Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer's Disease - Del Cerro_2018_CNS.Drugs_32_579
Author(s) : Del Cerro P , Alquezar C , Bartolome F , Gonzalez-Naranjo P , Perez C , Carro E , Paez JA , Campillo NE , Martin-Requero A
Ref : CNS Drugs , 32 :579 , 2018
Abstract :
PubMedSearch : Del Cerro_2018_CNS.Drugs_32_579
PubMedID: 29736745